Compare Lustrum:Perseus Proteomics Inc.:4882

※The values of financial statements might be different from the actual ones. Please confirm the original. [instructions]

Main FunctionHelp Company NameHelp CodeHelp Types of IndustryHelp Market Name Fiscal Year End Year of Listing
Browse U-Chart Add to 'Companies Comparison' list Compare Lustrum Ullet index Perseus Proteomics Inc. Go to web site 4882 Medicals 東証グロース March 1, 2000 2021.
Analysis u.gifU-Chart AnalysisHelp hikaku.gifAdd to 'Companies Comparison' listHelp u2.gifCompare LustrumHelp mark.gifUllet indexHelp
Accounts Information Balance Sheet Profit and Loss Account Cash Flow Statement
Display

Perseus Proteomics Inc. Balance Sheet(B/S)

[Show - Hide] U-Chart:Balance Sheet (B/S)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

Perseus Proteomics Inc. Balance Sheet 2024年3月期 Perseus Proteomics Inc. Balance Sheet 2023年3月期 Perseus Proteomics Inc. Balance Sheet 2022年3月期 Perseus Proteomics Inc. Balance Sheet 2021年3月期 Perseus Proteomics Inc. Balance Sheet 2020年3月期

[Show - Hide] Balance Sheet (B/S)Help  ※Unit:Millions of Yen

Accounting Date March 31, 2024 March 31, 2023 March 31, 2022 March 31, 2021 March 31, 2020
Cash and Cash Equivalents
(Percent)
1,541down
(91.0%)down
2,445down
(95.3%)down
3,215up
(97.4%)up
1,069up
(95.6%)up
482
(88.1%)
Other Current AssetsHelp
(Percent)
110up
(6.5%)up
70down
(2.7%)up
76up
(2.3%)down
40down
(3.5%)down
56
(10.2%)
Tangible Fixed AssetsHelp
(Percent)
0
-
0
-
0
-
0
-
0
-
Intangible Fixed AssetHelp
(Percent)
0
-
0
-
0
-
0
-
0
-
Investments and OthersHelp
(Percent)
43down
(2.5%)up
52up
(2.0%)up
10down
(0.3%)down
10up
(0.9%)down
10
(1.8%)
Total AssetsHelp
(Percent)
1,694
(100%)
2,567
(100%)
3,301
(100%)
1,119
(100%)
548
(100%)
Total Current LiabilitiesHelp
(Percent)
295up
(17.4%)up
170up
(6.6%)up
148up
(4.5%)up
35down
(3.1%)down
62
(11.3%)
Total Long-term LiabilitiesHelp
(Percent)
0
-
0
-
0
-
0
-
0
-
Shareholder's EquityHelp
(Percent)
1,398down
(82.6%)down
2,397down
(93.4%)down
3,152up
(95.5%)down
1,084up
(96.9%)up
486
(88.7%)
Total LiabilitiesHelp
(Percent)
1,694
(100%)
2,567
(100%)
3,301
(100%)
1,119
(100%)
548
(100%)

Perseus Proteomics Inc. Profit and Loss Account(P/L)

[表示非表示] U-Chart:Profit and Loss Account (P/L)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

Perseus Proteomics Inc. Profit and Loss Account 2024年3月期 Perseus Proteomics Inc. Profit and Loss Account 2023年3月期 Perseus Proteomics Inc. Profit and Loss Account 2022年3月期 Perseus Proteomics Inc. Profit and Loss Account 2021年3月期 Perseus Proteomics Inc. Profit and Loss Account 2020年3月期

[Show - Hide] Profit and Loss Account (P/L)Help  ※Unit:Millions of Yen

Accounting Date March 31, 2024 March 31, 2023 March 31, 2022 March 31, 2021 March 31, 2020
Amount of Sales
(Percent)
100
(100%)
94
(100%)
72
(100%)
68
(100%)
86
(100%)
Total Sales
(Percent)
100
(100%)
94
(100%)
72
(100%)
68
(100%)
86
(100%)
Cost of SalesHelp
(Percent)
13up
(12.7%)up
8up
(8.1%)up
4up
(5.8%)up
4down
(5.7%)down
6
(7.4%)
Other Costs and RevenueHelp 1,192up
(1,187.4%)up
874up
(927.3%)up
667up
(926.9%)up
477down
(702.5%)down
921
(1,074.1%)
Total CostsHelp 1,205 881 671 481 927
Net RevenueHelp 88up
(87.3%)down
87up
(91.9%)down
68up
(94.2%)down
64down
(94.3%)up
79
(92.6%)
Earnings Before TaxHelp -1,103down
(-1,098.1%)down
-785down
(-833.4%)down
-597down
(-830.1%)down
-411up
(-605.3%)up
-840
(-979.3%)
Net IncomeHelp -1,104down
(-1,100.0%)down
-787down
(-835.4%)down
-599down
(-832.8%)down
-413up
(-608.1%)up
-842
(-981.5%)
当期純利益 -1,104 -787 -599 -413 -842

Perseus Proteomics Inc. Cash Flow Statement(C/F)

[表示非表示] U-Chart:Cash Flow Statement (C/F)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

Perseus Proteomics Inc. Cash Flow Statement 2024年3月期 Perseus Proteomics Inc. Cash Flow Statement 2023年3月期 Perseus Proteomics Inc. Cash Flow Statement 2022年3月期 Perseus Proteomics Inc. Cash Flow Statement 2021年3月期 Perseus Proteomics Inc. Cash Flow Statement 2020年3月期

[Show - Hide] Cash Flow Statement (C/F)Help  ※Unit:Millions of Yen

Accounting Date March 31, 2024 March 31, 2023 March 31, 2022 March 31, 2021 March 31, 2020
Operating Cash Flow(OFC)Help
(Percent)
-834down
(-84.7%)down
-564down
(-72.6%)down
-477down
(-18.0%)up
-423up
(-41.8%)down
-609
(-18.6%)
Investing Cash Flow(ICF)Help
(Percent)
-150up
(-15.3%)up
-213down
(-27.4%)down
-34down
(-1.3%)down
-3up
(-0.3%)down
-3
(-0.1%)
Financing Cash FlowHelp
(Percent)
64up
(6.5%)up
-0down
(0.0%)down
2,648up
(99.7%)down
1,011down
(99.9%)up
2,648
(81.1%)
Exchange Difference of Cash and Cash EquivalentsHelp
(Percent)
17up
(1.7%)up
7down
(0.9%)up
9up
(0.3%)up
1up
(0.1%)up
-2,653
(-81.3%)
Net Increase and Decrease in Cash and Cash Equivalentsn -904down
(-91.8%)up
-770down
(-99.1%)down
2,146up
(80.8%)up
587up
(58.0%)up
-618
(-18.9%)

他社比較Help

Companies in 'Companies Comparison' list

Browsing historyHelp

Your reecently viewed companies

Perseus Proteomics Inc.

Company where related level is highHelp

Eisai Co.,Ltd.
JCR Pharmaceuticals Co.,Ltd.
MIKASA SEIYAKU CO.,LTD.
MUROMACHI CHEMICALS INC.
Fuso Pharmaceutical Industries, Ltd.
K Pharma,Inc.
Nxera Pharma Co., Ltd.
AnGes,Inc.
SanBio Company Limited
Takeda Pharmaceutical Company Limited